BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20011934)

  • 1. [Management of community acquired pneumonia in adults following clinical guidelines at a rural hospital].
    Sanhueza A LM; Vásquez P C; Sepúlveda Z F; Barahona C F; González C R; Saldías P F
    Rev Med Chil; 2009 Oct; 137(10):1283-90. PubMed ID: 20011934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals.
    Dudas V; Hopefl A; Jacobs R; Guglielmo BJ
    Ann Pharmacother; 2000 Apr; 34(4):446-52. PubMed ID: 10772428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Akram AR; Choudhury G; Mandal P; Hill AT
    J Antimicrob Chemother; 2011 Feb; 66(2):416-23. PubMed ID: 21081545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
    Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
    Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inpatient care of community-acquired pneumonia: the effect of antimicrobial guidelines on clinical outcomes and drug costs in Canadian teaching hospitals.
    Marras TK; Jamieson L; Chan CK
    Can Respir J; 2004 Mar; 11(2):131-7. PubMed ID: 15045044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
    Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
    Frei CR; Restrepo MI; Mortensen EM; Burgess DS
    Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality.
    Costantini E; Allara E; Patrucco F; Faggiano F; Hamid F; Balbo PE
    Intern Emerg Med; 2016 Oct; 11(7):929-40. PubMed ID: 27098057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.
    McCabe C; Kirchner C; Zhang H; Daley J; Fisman DN
    Arch Intern Med; 2009 Sep; 169(16):1525-31. PubMed ID: 19752411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical outcomes and antimicrobial compliance according to the Chilean Society of Respiratory Diseases guidelines for hospitalized patients with community acquired pneumonia].
    Díaz A; Kuzmanic G; Platzer L; Sanfuentes F; Espinoza MA; Saldías F
    Rev Med Chil; 2003 Aug; 131(8):847-56. PubMed ID: 14558238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription of antibiotics for adults hospitalized with community-acquired pneumonia in Korea in 2004: a population-based descriptive study.
    Yoon YK; Kim EJ; Chun BC; Eom JS; Park DW; Sohn JW; Kim MJ
    Respirology; 2012 Jan; 17(1):172-9. PubMed ID: 21995414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study.
    DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L
    Trials; 2015 Aug; 16():355. PubMed ID: 26272324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia.
    Lee RW; Lindstrom ST
    Respirology; 2007 Sep; 12(5):754-8. PubMed ID: 17875067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
    Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB;
    Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic treatment outcomes in community-acquired pneumonia.
    Çilli A; Sayıner A; Çelenk B; Şakar Coşkun A; Kılınç O; Hazar A; Aktaş Samur A; Taşbakan S; Waterer GW; Havlucu Y; Kılıç Ö; Tokgöz F; Bilge U
    Turk J Med Sci; 2018 Aug; 48(4):730-736. PubMed ID: 30119147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the Netherlands.
    Huijts SM; van Werkhoven CH; Boersma WG; Buijs J; Buunk G; Compaijen CJ; van Elde LJ; Gisolf JE; van der Kam R; Kluytmans JA; Kuipers BA; Mager JJ; Oppedijk B; Palmen F; Prins JM; van Reemst B; Silbermann MH; van Tiel FH; van der Wall E; van der Werf TS; Bonten MJ
    Neth J Med; 2013 Dec; 71(10):502-7. PubMed ID: 24394734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia.
    Ramirez JA; Srinath L; Ahkee S; Huang A; Raff MJ
    Arch Intern Med; 1995 Jun; 155(12):1273-6. PubMed ID: 7778957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
    Mortensen EM; Restrepo MI; Anzueto A; Pugh J
    Crit Care; 2005 Dec; 10(1):R8. PubMed ID: 16420641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project.
    Bratzler DW; Ma A; Nsa W
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S193-201. PubMed ID: 18986289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.